Are you Dr. Ewenstein?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 35 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
15 Claflin Path
Brookline, MA 02445Phone+1 617-731-9211- Is this information wrong?
Summary
- Dr. Bruce Ewenstein, MD is an oncologist in Brookline, Massachusetts. He is currently licensed to practice medicine in Massachusetts.
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1983 - 1986
Jacobi Medical Center/Albert Einstein College of MedicineResidency, Internal Medicine, 1980 - 1983
Albert Einstein College of MedicineClass of 1980
Certifications & Licensure
MA State Medical License 1984 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
Clinical Trials
- ADVATE Post Authorization Safety Surveillance Start of enrollment: 2004 Oct 14
- Phase 1 Dose Escalation, Single Dose Study to Assess Safety and Pharmacokinetics of BAX930 in Hereditary Thrombotic Thrombocytopenic Purpura (TTP) Start of enrollment: 2014 Sep 30
- A Study of BAX 930 in Children, Teenagers, and Adults Born With Thrombotic Thrombocytopenic Purpura (TTP) Start of enrollment: 2017 Oct 13
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsEtranacogene dezaparvovec gene therapy for haemophilia B (HOPE-B): 24-month post-hoc efficacy and safety data from a single-arm, multicentre, phase 3 trial.Michiel Coppens, Steven W Pipe, Wolfgang Miesbach, Jan Astermark, Michael Recht, Paul van der Valk, Bruce Ewenstein, Karen Pinachyan, Nicholas Galante, Sandra Le Quell...> ;The Lancet. Haematology. 2024 Apr 1
- Inhibition of protein arginine deiminase 4 prevents inflammation-mediated heart failure in arthritis.Lukas A Heger, Nicolas Schommer, Shoichi Fukui, Stijn Van Bruggen, Casey E Sheehy, Long Chu, Sridharan Rajagopal, Dhanalakshmi Sivanandhan, Bruce Ewenstein, Denisa D W...> ;Life Science Alliance. 2023 Oct 1
- 1 citationsEvaluation of collagen turnover biomarkers as an objective measure for efficacy of treatment with rurioctocog alfa pegol in patients with hemophilia A: a secondary ana...Tina Manon-Jensen, Srilatha Tangada, Cecilie Bager, Pratima Chowdary, Robert Klamroth, Annette von Drygalski, Jerzy Windyga, Miguel Escobar, Peder Frederiksen, Werner ...> ;Journal of Thrombosis and Haemostasis. 2024 Jan 1
- Join now to see all
Press Mentions
Results of a Randomized Phase III/IV Trial Comparing Intermittent Bolus Versus Continuous Infusion of Antihaemophilic Factor (Recombinant) in Adults with Severe or Moderately Severe Haemophilia A Undergoing Major Orthopaedic SurgeryMarch 27th, 2021
Shire to Present New Data at Isth 2017 to Advance the Standard of Care in HemophiliaJune 23rd, 2017
Shire to Present New Data at Isth 2017 to Advance the Standard of Care in HemophiliaJune 23rd, 2017- Join now to see all
